Carson Wealth (CWM LLC)
ATNM icon

Carson Wealth (CWM LLC)’s Actinium Pharmaceuticals ATNM Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio ATNM Stock Details ATNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$349 Sell
351
-269
-43% -$320 ﹤0.01% 5488
2025
Q4 		$1K Sell
620
-775
-56% -$1.13K ﹤0.01% 5167
2025
Q3 		$2K Sell
1,395
-6,150
-82% -$10K ﹤0.01% 4972
2025
Q2 		$11K Buy
7,545
+1,072
+17% +$1.6K ﹤0.01% 4225
2025
Q1 		$10K Buy
6,473
+5,463
+541% +$6.93K ﹤0.01% 4090
2024
Q4 		$1K Sell
1,010
-2,193
-68% -$3.4K ﹤0.01% 4654
2024
Q3 		$6K Buy
3,203
+3,101
+3,040% +$12.3K ﹤0.01% 3983
2024
Q2 		$1K Buy
102
+11
+12% +$91 ﹤0.01% 4305
2024
Q1 		$1K Sell
91
-86
-49% -$553 ﹤0.01% 4070
2023
Q4 		$1K Buy
177
+77
+77% +$397 ﹤0.01% 3892
2023
Q3 		$1K Hold
100
– – ﹤0.01% 3920
2023
Q2 		$1K Hold
100
– – ﹤0.01% 3904
2023
Q1 		$1K Hold
100
– – ﹤0.01% 3770
2022
Q4 		$1K Sell
100
-1,522
-94% -$15.4K ﹤0.01% 3688
2022
Q3 		$12K Hold
1,622
– – ﹤0.01% 2548
2022
Q2 		$8K Hold
1,622
– – ﹤0.01% 2681
2022
Q1 		$8K Hold
1,622
– – ﹤0.01% 2588
2021
Q4 		$10K Buy
+1,622
New +$12.2K ﹤0.01% 2335
2021
Q2 		$12K Hold
1,498
– – ﹤0.01% 2010
2021
Q1 		$12K Hold
1,498
– – ﹤0.01% 2010
2020
Q4 		$12K Hold
1,498
– – ﹤0.01% 2010
2020
Q3 		$12K Buy
1,498
+1,448
+2,896% +$16K ﹤0.01% 2010
2020
Q2 		$12K Hold
50
– – ﹤0.01% 2010
2020
Q1 		$12K Hold
50
– – ﹤0.01% 2010
2019
Q4 		$12K Hold
50
– – ﹤0.01% 2010
2019
Q3 		$12K Hold
50
– – ﹤0.01% 2010
2019
Q2 		$12K Hold
50
– – ﹤0.01% 2010
2019
Q1 		$12K Buy
+50
New +$798 ﹤0.01% 2010

Other funds holding ATNM

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Carson Wealth (CWM LLC)'s ATNM Position: Q1 2026 in Review

Carson Wealth (CWM LLC) reduced its Actinium Pharmaceuticals (ATNM) stake by 43% in Q1 2026, selling an estimated $320 and leaving 351 shares worth $349. The position accounts for ﹤0.01% of the portfolio, ranked #5488.

Carson Wealth (CWM LLC) first reported a position in ATNM in Q1 2019 and has held it in 28 quarters since. The position peaked at $12K in Q3 2022. 54 funds tracked by Wall St. Rank hold ATNM as of Q1 2026.

  • Carson Wealth (CWM LLC) held 351 shares of Actinium Pharmaceuticals worth $349 as of Q1 2026.
  • Carson Wealth (CWM LLC) sold 269 Actinium Pharmaceuticals shares in Q1 2026, an estimated $320.
  • Actinium Pharmaceuticals made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #5488 holding.
  • Carson Wealth (CWM LLC) first reported a position in Actinium Pharmaceuticals in Q1 2019 and has held it in 28 quarters since.
  • Carson Wealth (CWM LLC)'s Actinium Pharmaceuticals position peaked at $12K in Q3 2022.
  • 54 funds tracked by Wall St. Rank held Actinium Pharmaceuticals as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.